4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-010952
President & CEO sold 19,635 shares at $3.00 ($58,905)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2023-02-16 | Sale | −19,635 | $3.00 | $58,905 | 960,158 | D |
| Open-market sales · 19,635 sh · avg $3.00 · $58,905 | |||||||
Loading xslF345X03/doc4.xml…